Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies

被引:4
作者
Chandra, Anshuman [1 ]
Goyal, Nainee [1 ]
Qamar, Imteyaz [1 ]
Singh, Nagendra [1 ]
机构
[1] Gautam Buddha Univ, Sch Biotechnol, Greater Noida 201312, Uttar Pradesh, India
关键词
Molecular dynamics simulation; hot spot residues; cancer; specific inhibitors; PROCESSIVE PHOSPHORYLATION; SR;
D O I
10.1080/07391102.2020.1734487
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine-arginine protein kinase-1 (SRPK1) is a highly specific kinase that recognizes serine-arginine dipeptide repeats and phosphorylates SR rich splicing factor ASF/SF2 in a cell-cycle regulated manner. SRPK1 processively phosphorylates serine residues on its substrate ASF/SF2. Elevated expression pattern of both SRPK1 and ASF/SF2 and their association with various carcinomas have established SRPK1 as a potent target for drug design against cancers. In order to develop specific inhibitors the binding of ASF/SF2 to SRPK1 is desired to be selectively interrupted. We have performed molecular dynamics simulation studies on crystal structure of SRPK1 complex with ASF/SF2. The ASF/SF2 acquired a stable binding on the surface of SRPK1 with strong attractive forces. Analysis revealed that there was no major position shifting of the core beta-sheet region within the catalytic site of SRPK1 when present in the state of ASF/SF2 bound in comparison to apo form. Global motions of SRPK1 indicated that major stable structural changes occurred after the substrate binding. The interactions between SRPK1 and ASF/SF2 were examined and calculated during molecular dynamics simulation of 1 mu s. Molecular dynamics study indicated Arg84, Lys85, Leu86, Lys174, Tyr227 and Leu479 residues of SRPK1 as essential hot spots involved in the stable binding with substrate. Structural analysis of the binding affinity and hot spot investigation provided significant information on ASF/SF2 binding which may also be considered for designing of the novel specific inhibitors of SRPK1 for the applications in cancer therapy. Communicated by Ramaswamy H. Sarma
引用
收藏
页码:1579 / 1587
页数:9
相关论文
共 25 条
  • [21] Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease
    Shukla, Rohit
    Singh, Tiratha Raj
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (01) : 248 - 262
  • [22] Molecular docking/dynamics studies of Aurora A kinase inhibitors
    Talele, Tanaji T.
    McLaughlin, Mark L.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 26 (08) : 1213 - 1222
  • [23] BDB: Databank of PDB files with consistent B-factors
    Touw, Wouter G.
    Vriend, Gert
    [J]. PROTEIN ENGINEERING DESIGN & SELECTION, 2014, 27 (11) : 457 - 462
  • [24] GROMACS: Fast, flexible, and free
    Van der Spoel, D
    Lindahl, E
    Hess, B
    Groenhof, G
    Mark, AE
    Berendsen, HJC
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) : 1701 - 1718
  • [25] Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
    van Roosmalen, Wies
    Le Devedec, Sylvia E.
    Golani, Ofra
    Smid, Marcel
    Pulyakhina, Irina
    Timmermans, Annemieke M.
    Look, Maxime P.
    Zi, Di
    Pont, Chantal
    de Graauw, Marjo
    Naffar-Abu-Amara, Suha
    Kirsanova, Catherine
    Rustici, Gabriella
    't Hoen, Peter A. C.
    Martens, John W. M.
    Foekens, John A.
    Geiger, Benjamin
    van de Water, Bob
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (04) : 1648 - 1664